ID | Sex | Diagnosis | Initial sympton | NYS | Age of onset (y) | Age at visit (y) | BCVA (decimal) OD/OS | ERG (scotopic/photopic) | VF |
---|---|---|---|---|---|---|---|---|---|
F1-III:4 | M | RP, HM | Night blindness | N | 39 | 46 | 0.4/0.6 | NA | Constricted |
F2-III:3 | M | RP, MC | Night blindness. Central vision impairment | N |  < 1 | 27 | 0.1/0.1 | Both severely reduced | NA |
F3-III:5 | F | RP | Night blindness | N | 20 | 51 | LP | NA | NA |
F4-III:4 | F | RP | Night blindness | N | 20 | 60 | HM/HM | Both severely reduced | NA |
F5-III:1 | M | RP | Night blindness | N | 14 | 34 | 0.5/0.6 | Both severely reduced | Constricted |
F6-III:1 | F | RP | Night blindness | N | 6 | 23 | 0.8/0.6 | Severely reduced/slightly reduced | Constricted |
F7-III:4 | M | CORD, POAG | Central vision impairment | N | 40 | 45 | CF at 1Â m/0.02 | Both severely reduced | Central scotoma |
F8-III:5 | F | CORD | Central vision impairment | N | 32 | 43 | CF at 40Â cm/0.01 | Both severely reduced, greater loss in cone | Central scotoma |
F9-III:2 | M | BCD | Night blindness | N | 43 | 44 | 0.6/0.8 | Severely reduced/slightly reduced | Constricted |
F10-III:1 | F | LCA | Vision impairment | Y |  < 1 | 29 | HM/HM | Extinguished | NA |